Partilhar
Informação da revista
Número
Páginas 183-266 (Março 2022)
Original articles
NT-proBNP for heart failure diagnosis in Primary Care: Costs or savings? A budget impact study
Cândida Fonseca, Paulo Bettencourt, Dulce Brito, Helena Febra, Álvaro Pereira, Victória Genovez, Nelson Lopes
Rev Port Cardiol. 2022;41:183-93
Open access
Original articles
Editorial comment
Natriuretic peptides for heart failure patients in primary care: Today more than ever
Paulo Santos
Rev Port Cardiol. 2022;41:195-6
Open access
Comparison of protective effects of alprostadil with Salvia miltiorrhiza against myocardial ischemia-reperfusion injury in rats
Jing Liu, Hui-Bo Chen, Wei-Zhi Sun, Xiao-Xia Jin, Wei Zhang, Yan-Bo Yang, Ya-Ru Li, Xiu-Li Chen, Jing-Bo Hou
Rev Port Cardiol. 2022;41:197-205
Open access
A new weapon in the armamentarium to tackle inflammation associated with myocardial infarction
Maria Vasconcelos-Cardoso, Henrique Girao
Rev Port Cardiol. 2022;41:207-8
Open access
Digital home-based multidisciplinary cardiac rehabilitation: How to counteract physical inactivity during the COVID-19 pandemic
Rita Pinto, Madalena Lemos Pires, Mariana Borges, Mariana Liñan Pinto, Catarina Sousa Guerreiro, Sandra Miguel, Olga Santos, Inês Ricardo, ... Ana Abreu
Rev Port Cardiol. 2022;41:209-18
Open access
Stent-Save a Life international survey on the practice of primary percutaneous coronary intervention during the COVID-19 pandemic
Hélder Pereira, Christoph Naber, Sandrine Wallace, Tóth Gabor, Sayfollah Abdi, Bagrat Alekyan, Thomas Alexander, Carolina Artucio, ... Jan Piek
Rev Port Cardiol. 2022;41:221-7
Open access
Impact of the first COVID-19 wave on quality of care in acute coronary syndrome – the importance of information for health policy design
Eduardo Infante de Oliveira
Rev Port Cardiol. 2022;41:229-30
Open access
State of the art
Congenital atrioventricular heart block: From diagnosis to treatment
Clara Melim, Joana Pimenta, José Carlos Areias
Rev Port Cardiol. 2022;41:231-40
Open access
Guidelines
Documento de Consenso sobre Estratificação de Risco Cardiovascular e estudo da doença coronária em Portugal: a posição dos Grupos de Estudo de Cardiologia Nuclear, Ressonância Magnética e Tomografia Computorizada Cardíaca, de Ecocardiografia e de Fisiopatologia do Esforço e Reabilitação Cardíaca
Nuno Bettencourt, Lígia Mendes, José Paulo Fontes, Pedro Matos, Catarina Ferreira, Ana Botelho, Sofia Carvalho, Anaí Durazzo, ... em nome do GECNRMTC, do GEE e do GEFERC da SPC
Rev Port Cardiol. 2022;41:241-51
Open access
Case report
Left ventricular noncompaction associated with a pathogenic mutation in the MYH7 gene: Known mutation, different phenotype
Margarida Oliveira, Olga Azevedo, Bebiana Faria, Pedro von Hafe, Geraldo Dias, Ricardo Faria, Victor Sanfins, Mário Lourenço, ... António Lourenço
Rev Port Cardiol. 2022;41:253-9
Open access
Case Report
Editorial comment
Left ventricular non-compaction: Challenges in the etiopathogenesis and risk stratification of sudden cardiac death in clinical practice
Nuno Marques
Rev Port Cardiol. 2022;41:261-2
Open access
Imagem em cardiologia
Left atrial appendage thrombosis discovered by transthoracic echocardiography
Amedeo Pergolini, Giordano Zampi, Daniele Pontillo
Rev Port Cardiol. 2022;41:263-4
Open access
Letter to the editor
Estudo da doença coronária em Portugal: haverá vida para além da Covid?
Nuno Bettencourt, Lígia Mendes, José Paulo Fontes
Rev Port Cardiol. 2022;41:265-6
Open access
Conteúdo especial sobre COVID-19
- Reply to: RAAS inhibitors in COVID-19: Not all are created equal. Telmisartan is the one
- RAAS inhibitors in COVID-19: not all are created equal. Telmisartan is the one
- High prevalence of cardiovascular disease and risk factors among type 2 diabetes patients followed in a hospital setting in Portugal
- RAAS inhibitors in COVID-19: They are not all the same!
Publicar em
Revista Portuguesa de Cardiologia
A revista pertence ao Committee on Publication Ethics (COPE) www.publicationethics.org e adere aos seus princípios e procedimentos.